tirzepatide interaction with birth control Can the new diabetes and weight loss drugs affect reproductive health? — Those Nerdy Girls MHRA urges women taking weight-loss

May;326(7397):10081008

A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice The study examines the effectiveness of novel peptides that are a combination of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon

The pulsatility argument in favor of secretagogues over exogenous GH applies to CJC 1295 without DAC, not to the DAC form

Spleen weight and the aggregated weight of lymph nodes were not decreased by the treatment in mice with detectable tumors (Fig